These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4393047)

  • 1. [Case of ventricular tachycardia with specific reaction to quinidine sulfate and with remarkable therapeutic effect with propranolol (a beta-sympathetic receptor blockader)].
    Hinohara S; Shinoda T; Igarashi M; Shibagaki M
    Naika; 1970; 25(5):974-6. PubMed ID: 4393047
    [No Abstract]   [Full Text] [Related]  

  • 2. [Life-threatening disorders of the heart rhythm and beta receptor blocking agents].
    Tschirdewahn B; Knorpp K; Heinrich F; Schütterle G
    Dtsch Med Wochenschr; 1967 Dec; 92(48):2204-8. PubMed ID: 6057149
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of beta-blockade therapy for ventricular tachycardia induced with isoproterenol: a prospective analysis.
    DiCarlo LA; Susser F; Winston SA
    Am Heart J; 1990 Dec; 120(6 Pt 1):1347-55. PubMed ID: 1978977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experiences with -receptor blockader Propranolol in the treatment of angina pectoris and tachycrdiac arrhythmias].
    Eisenreich R
    Z Arztl Fortbild (Jena); 1970 Jun; 64(11):529-34. PubMed ID: 4106268
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of ventricular tachycardia in an infant.
    Sanchez J; Christie K; Cumming GR
    Can Med Assoc J; 1972 Jul; 107(2):136-8. PubMed ID: 5041936
    [No Abstract]   [Full Text] [Related]  

  • 6. Propranolol and quinidine in the management of ventricular tachycardia.
    Dreifus LS; Lim HF; Watanabe Y; McKnight E; Frank MN
    JAMA; 1968 May; 204(8):736-7. PubMed ID: 5694520
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
    Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME
    Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological therapy and prevention of recurrent ventricular tachycardia].
    Vajola SF; Chiavarelli V; Milazzotto F
    G Ital Cardiol; 1981; 11(11):1743-9. PubMed ID: 7343378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

  • 10. Refractory paroxysmal ventricular tachycardia.
    Zipes DP; Orgain ES
    Ann Intern Med; 1967 Dec; 67(6):1251-7. PubMed ID: 6061939
    [No Abstract]   [Full Text] [Related]  

  • 11. Corticosteroids in ventricular tachycardia.
    Zammit Maempel JV
    Isr J Med Sci; 1974 Sep; 10(9):1126-32. PubMed ID: 4436036
    [No Abstract]   [Full Text] [Related]  

  • 12. Repetitive ventricular tachycardia--response to cardioversion, potassium and digitalis.
    Gotsman MS; Pimstone NR
    S Afr Med J; 1967 May; 41(19):487-9. PubMed ID: 4381879
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is there a beta receptor excitability syndrome? (action of an inhibitor, propranolol, on resistant sinusal tachycardia].
    Linquette M; Belbenoit C; Mesmacque R; May JP; Fourlinnie JC; Hubschman B
    Lille Med; 1967 Nov; 12(9):1154-62. PubMed ID: 4394059
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic difficulties in supraventricular tachycardia without any evident changes in the heart].
    Janukowicz C
    Pol Tyg Lek; 1973 Nov; 28(47):1861-2. PubMed ID: 4771542
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effectiveness of lignocaine, quinidine, propranolol and procainamide as antifibrillatory agents.
    Murnaghan MF
    Br J Pharmacol; 1970 Sep; 40(1):149P. PubMed ID: 5487011
    [No Abstract]   [Full Text] [Related]  

  • 16. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
    Meltzer RS; Robert EW; McMorrow M; Martin RP
    Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of impact-induced tachyarrhythmia utilizing propranolol, quinidine and pacing.
    Lau IV
    J Electrocardiol; 1985 Apr; 18(2):151-6. PubMed ID: 2987385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia.
    Wellens HJ; Bär FW; Lie KI; Düren DR; Dohmen HJ
    Am J Cardiol; 1977 Oct; 40(4):579-85. PubMed ID: 910721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The function of newer antiarrhythmic drugs under special consideration of beta blocking adrenergic agents.
    Shalsha KG
    Proc Rudolf Virchow Med Soc City N Y; 1968-1969; 27():201-11. PubMed ID: 4402617
    [No Abstract]   [Full Text] [Related]  

  • 20. Recognition and management of supraventricular tachyarrhythmias.
    Tonkin A
    Aust N Z J Med; 1981 Dec; 11(6):697-705. PubMed ID: 6949547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.